Kronos Bio, Inc. financial data

Symbol
KRON on Nasdaq
Location
1300 S. El Camino Real, Suite 400, San Mateo, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 881 % +7.05%
Debt-to-equity 36.1 % +13%
Return On Equity -64.2 % +6.48%
Return On Assets -47.2 % +9.32%
Operating Margin -765 % +53.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61M shares +1.46%
Common Stock, Shares, Outstanding 61M shares +1.46%
Entity Public Float 46.3M USD -4.14%
Common Stock, Value, Issued 61K USD +1.67%
Weighted Average Number of Shares Outstanding, Basic 60.8M shares +2.16%
Weighted Average Number of Shares Outstanding, Diluted 60.8M shares +2.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.19M USD +21.2%
Research and Development Expense 36.6M USD -53.8%
General and Administrative Expense 23.2M USD -36.2%
Operating Income (Loss) -70.3M USD +44%
Nonoperating Income (Expense) 5.85M USD -36.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -64.5M USD +44.6%
Earnings Per Share, Basic -1 USD/shares +46.2%
Earnings Per Share, Diluted -1 USD/shares +46.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91.6M USD +98.2%
Assets, Current 102M USD -35.7%
Property, Plant and Equipment, Net 1.08M USD -86.7%
Operating Lease, Right-of-Use Asset 3.05M USD -78.1%
Other Assets, Noncurrent 112K USD -80.6%
Assets 108M USD -40.9%
Accounts Payable, Current 1.57M USD -29.5%
Employee-related Liabilities, Current 148K USD -85.2%
Accrued Liabilities, Current 7.62M USD -32.8%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 7.88M USD -58.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 20.4M USD -16.4%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 28.3M USD -38.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -603M USD -12%
Stockholders' Equity Attributable to Parent 79.8M USD -41.7%
Liabilities and Equity 108M USD -40.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.8M USD +46.3%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 19.8M USD +244%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 61M shares +1.46%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.01M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 93.6M USD +94.1%
Deferred Tax Assets, Valuation Allowance 141M USD +15%
Deferred Tax Assets, Gross 142M USD +11.9%
Operating Lease, Liability 24.1M USD -12.3%
Depreciation 1.74M USD -20%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -64.4M USD +44.5%
Lessee, Operating Lease, Liability, to be Paid 30.8M USD -15.6%
Property, Plant and Equipment, Gross 4.5M USD -71.7%
Operating Lease, Liability, Current 3.64M USD +20.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.87M USD -9.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.41M USD -8.72%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.7M USD -25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.02M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 80.7M USD +18.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.29M USD +21.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.17M USD +3.01%
Operating Lease, Payments 5.9M USD -3.28%
Additional Paid in Capital 683M USD +1.08%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 220K USD -53.7%
Deferred Tax Assets, Net of Valuation Allowance 191K USD -94.6%
Share-based Payment Arrangement, Expense 7.04M USD -73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%